CY1111878T1 - Φαρμακευτικο σκευασμα για τη θεραπεια του ανωτερoy πεπτικου σωληνα - Google Patents

Φαρμακευτικο σκευασμα για τη θεραπεια του ανωτερoy πεπτικου σωληνα

Info

Publication number
CY1111878T1
CY1111878T1 CY20111100274T CY111100274T CY1111878T1 CY 1111878 T1 CY1111878 T1 CY 1111878T1 CY 20111100274 T CY20111100274 T CY 20111100274T CY 111100274 T CY111100274 T CY 111100274T CY 1111878 T1 CY1111878 T1 CY 1111878T1
Authority
CY
Cyprus
Prior art keywords
treatment
pharmaceutical preparation
upper dental
dental tube
tube
Prior art date
Application number
CY20111100274T
Other languages
Greek (el)
English (en)
Inventor
Markus Dr Pröls
Rudolf Dr Wilhelm
Original Assignee
Dr. Falk Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39951664&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1111878(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dr. Falk Pharma Gmbh filed Critical Dr. Falk Pharma Gmbh
Publication of CY1111878T1 publication Critical patent/CY1111878T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
CY20111100274T 2008-07-21 2011-03-11 Φαρμακευτικο σκευασμα για τη θεραπεια του ανωτερoy πεπτικου σωληνα CY1111878T1 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08013091A EP2151235B1 (de) 2008-07-21 2008-07-21 Pharmazeutische Formulierung zur Behandlung des oberen Verdauungstraktes

Publications (1)

Publication Number Publication Date
CY1111878T1 true CY1111878T1 (el) 2015-11-04

Family

ID=39951664

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20111100274T CY1111878T1 (el) 2008-07-21 2011-03-11 Φαρμακευτικο σκευασμα για τη θεραπεια του ανωτερoy πεπτικου σωληνα
CY20131100174T CY1113719T1 (el) 2008-07-21 2013-02-26 Φαρμακευτικο σκευασμα για τη θεραπεια του ανωτερου πεπτικου σωληνα

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20131100174T CY1113719T1 (el) 2008-07-21 2013-02-26 Φαρμακευτικο σκευασμα για τη θεραπεια του ανωτερου πεπτικου σωληνα

Country Status (23)

Country Link
US (2) US8580300B2 (enExample)
EP (2) EP2151235B1 (enExample)
JP (2) JP5616889B2 (enExample)
CN (1) CN102159196B (enExample)
AT (1) ATE498396T1 (enExample)
AU (1) AU2009273361B2 (enExample)
CA (1) CA2731312C (enExample)
CY (2) CY1111878T1 (enExample)
DE (1) DE502008002621D1 (enExample)
DK (2) DK2151235T3 (enExample)
EA (1) EA018465B1 (enExample)
ES (2) ES2358158T3 (enExample)
HR (2) HRP20130171T1 (enExample)
IL (1) IL210779A (enExample)
ME (2) ME01256B (enExample)
NZ (1) NZ590593A (enExample)
PL (2) PL2151235T3 (enExample)
PT (2) PT2151235E (enExample)
RS (2) RS51649B (enExample)
SI (2) SI2151235T1 (enExample)
UA (1) UA100759C2 (enExample)
WO (1) WO2010009961A1 (enExample)
ZA (1) ZA201100283B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8895064B2 (en) * 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
DE60005819T2 (de) 1999-06-14 2004-05-06 Cosmo S.P.A. Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
ME01256B (me) * 2008-07-21 2013-06-20 Dr Falk Pharma Gmbh Farmaceutska formulacija za lečenje gornjeg digestivnog trakta
WO2010144865A2 (en) 2009-06-12 2010-12-16 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
EP2482822B1 (en) 2009-10-01 2018-08-01 Adare Pharmaceuticals, Inc. Orally administered corticosteroid compositions
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
DK2886108T4 (da) 2013-12-23 2023-01-30 Dr Falk Pharma Gmbh Optimeret farmaceutisk formulering til behandling af inflammatoriske ændringer af øsofagus
TWI777515B (zh) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
ES3043383T3 (en) 2018-10-24 2025-11-25 Ferring Bv Mucoadhesive pharmaceutical compositions of corticosteroids

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4332394A1 (de) 1993-09-23 1995-03-30 Falk Pharma Gmbh Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
US5639475A (en) * 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
US5607697A (en) * 1995-06-07 1997-03-04 Cima Labs, Incorporated Taste masking microparticles for oral dosage forms
US5807577A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
US5807578A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
GB9611364D0 (en) * 1996-05-31 1996-08-07 Smithkline Beecham Plc Composition
US6350470B1 (en) * 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
JP3818789B2 (ja) * 1999-02-18 2006-09-06 三菱化学フーズ株式会社 易崩壊性錠剤
JP4038772B2 (ja) 2001-07-11 2008-01-30 敏朗 関根 光合成微生物の培養方法と装置
JP2005519865A (ja) * 2001-09-25 2005-07-07 ランバクシー ラボラトリーズ リミテッド 急速溶解性投薬形態物の製造方法
AU2002348301B2 (en) * 2001-11-20 2008-05-08 Dmi Biosciences, Inc. Methods and products for oral care
EP1487419A2 (en) * 2002-03-20 2004-12-22 Elan Pharma International Limited Fast dissolving dosage forms having reduced friability
SE0401031D0 (sv) * 2004-04-22 2004-04-22 Duocort Ab A new glucocorticoid replacement therapy
US20060013873A1 (en) * 2004-07-16 2006-01-19 Chih-Chiang Yang Bioadhesive dosage form of steroids
US20070071817A1 (en) * 2005-09-26 2007-03-29 Phyzz, Inc. Effervescent oral care compositions and method of use
WO2007095341A2 (en) * 2006-02-15 2007-08-23 Tika Läkemedel Ab Sterilization of corticosteroids with reduced mass loss
WO2009000473A2 (en) * 2007-06-22 2008-12-31 Dompe Pha.R.Ma S.P.A. Effervescent tablets for inhalatory use
PT2572705T (pt) * 2007-10-01 2017-11-08 Lesvi Laboratorios Sl Comprimidos orodispersíveis
ME01256B (me) * 2008-07-21 2013-06-20 Dr Falk Pharma Gmbh Farmaceutska formulacija za lečenje gornjeg digestivnog trakta
WO2010144865A2 (en) * 2009-06-12 2010-12-16 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders

Also Published As

Publication number Publication date
DK2306988T3 (da) 2013-03-18
DK2151235T3 (da) 2011-04-11
IL210779A0 (en) 2011-03-31
ME01256B (me) 2013-06-20
JP2014221827A (ja) 2014-11-27
EA018465B1 (ru) 2013-08-30
PL2151235T3 (pl) 2011-05-31
ES2358158T3 (es) 2011-05-06
EP2151235A1 (de) 2010-02-10
ATE498396T1 (de) 2011-03-15
RS51649B (sr) 2011-10-31
US20110123460A1 (en) 2011-05-26
SI2151235T1 (sl) 2011-04-29
EP2151235B1 (de) 2011-02-16
HRP20130171T1 (hr) 2013-03-31
CY1113719T1 (el) 2016-06-22
PL2306988T3 (pl) 2013-04-30
EP2306988A1 (de) 2011-04-13
SI2306988T1 (sl) 2013-03-29
JP5616889B2 (ja) 2014-10-29
ZA201100283B (en) 2011-10-26
US20140079646A1 (en) 2014-03-20
NZ590593A (en) 2012-07-27
AU2009273361B2 (en) 2014-03-20
CA2731312C (en) 2016-05-10
AU2009273361A1 (en) 2010-01-28
ME01494B (me) 2014-04-20
PT2151235E (pt) 2011-03-21
HK1149907A1 (en) 2011-10-21
IL210779A (en) 2015-07-30
EA201100229A1 (ru) 2011-08-30
EP2306988B1 (de) 2013-01-09
DE502008002621D1 (de) 2011-03-31
HRP20110208T1 (hr) 2011-04-30
CA2731312A1 (en) 2010-01-28
CN102159196A (zh) 2011-08-17
UA100759C2 (uk) 2013-01-25
US8580300B2 (en) 2013-11-12
RS52662B (sr) 2013-06-28
JP6209495B2 (ja) 2017-10-04
PT2306988E (pt) 2013-02-15
CN102159196B (zh) 2013-05-08
JP2011528679A (ja) 2011-11-24
WO2010009961A1 (de) 2010-01-28
ES2399321T3 (es) 2013-03-27

Similar Documents

Publication Publication Date Title
CY1113719T1 (el) Φαρμακευτικο σκευασμα για τη θεραπεια του ανωτερου πεπτικου σωληνα
HUS2100018I1 (hu) Hatóanyagok légúti beadására alkalmas készítmények és ezekkel kapcsolatos eljárások
IL255752B (en) Compounds, pharmaceutical compositions comprising the same and uses thereof for treating cardiovasclar disease, an inflammatory disease or cancer
LTC2137143I2 (lt) Pleuromutilino dariniai, skirti mikrobų sukeltų ligų gydymui
DK2010190T3 (da) Farmaceutisk opløsningsformulering til tryksatte, dosisregulerede inhalatorer
EA201300669A1 (ru) Замещенные 1-бензилциклоалкилкарбоновые кислоты и их применение
EP2399168A4 (en) CHEMICALLY REINFORCED RESISTANT COMPOSITION AND MOLDING PROCESS THEREFOR AND RESIST FILM THEREWITH
MX2013006591A (es) Formas farmaceuticas orales de liberacion controlada de farmacos escasamente solubles y los usos de estas.
EA201101190A1 (ru) Фармацевтическая композиция, включающая линаглиптин и необязательно ингибитор sglt2, и ее применение
MX2012001974A (es) Compuestos de biarilo y metodos de uso de los mismos.
DK2491942T3 (da) Anvendelse af cellepermeable peptidinhibitorer af JNK-signaltransduktionsvejen til behandling af forskellige kardiovaskulære sygdomme.
CY1115254T1 (el) Φαρμακευτικα διαλυματα, διαδικασιες για την παρασκευη τους και θεραπευτικες χρησεις
DK2462116T3 (da) Fremgangsmåde til fremstillingen af farmaceutisk aktive forbindelser
FR2953142B1 (fr) Appareil de delivrance regulee d'un gaz,notamment appareil d'assistance respiratoire
DOP2012000170A (es) Proceso para la fabricacion de un agente farmaceuticamante activo
CY1116831T1 (el) ΧΡΗΣΗ 24-norUDCA
DK2422786T3 (da) Nye lægemiddelkombinationer til behandling af luftvejssygdomme
WO2011072069A3 (en) Gastric retentive pharmaceutical compositions for extended release of polypeptides
EE201300004A (et) Kombineeritud ravimkoostis sdame-veresoonkonnaga seotud haiguste v?i seisundite raviks
EA201071209A1 (ru) Применение дронедарона или его фармацевтически приемлемой соли для получения лекарственного средства для регуляции уровня калия в крови
DK2101730T3 (da) Galenisk form til transmucosal indgivelse af paracetamol
DK1940409T3 (da) Nye lægemiddelkombinationer til behandling af åndedrætssygdomme
MX339619B (es) Formulaciones, sales y polimorfos de transnorsertralina y usos de los mismos.
DK1856070T3 (da) Nye lægemidler til behandling af luftvejssygdomme
DK2310091T3 (da) Ioniseret gas til medicinsk behandling